Ph1/2a FIH study to assess activity of DB-1311 in subjects with Solid Tumors

Phase: Phase I/II Clinical Trial
Condition(s): Cervical Cancer, Esophageal Cancer, Liver Cancer, Melanoma
Trial Number: 05914116
Trial Status: OPEN

Study Overview

A Phase 1/2a Multicenter Open-Label First in Human Study to Assess the Safety Tolerability Pharmacokinetics and Preliminary Antitumor Activity of DB-1311 in Subjects With Advanced/Metastatic Solid Tumors (DB-1311-O-1001)

Learn More About This Study

Participating Locations

‌

‌
‌

Ph1/2a FIH study to assess activity of DB-1311 in subjects with Solid Tumors

Study Overview

Participating Locations

Loading component...

Ph1/2a FIH study to assess activity of DB-1311 in subjects with Solid Tumors

Study Overview

Participating Locations